Your browser doesn't support javascript.
loading
Urine soluble TLR4 levels may contribute to predict urinary tract infection in children: the UTILISE Study.
Aksu, Bagdagul; Afonso, Alberto Caldas; Akil, Ipek; Alpay, Harika; Atmis, Bahriye; Aydog, Ozlem; Bayazit, Aysun Karabay; Bayram, Meral Torun; Bilge, Ilmay; Bulut, Ipek Kaplan; Buyukkaragoz, Bahar; Comak, Elif; Demir, Belde Kasap; Dincel, Nida; Donmez, Osman; Durmus, Mehmet Akif; Dursun, Hasan; Dusunsel, Ruhan; Duzova, Ali; Ertan, Pelin; Gedikbasi, Asuman; Goknar, Nilufer; Guven, Sercin; Hacihamdioglu, Duygu; Jankauskiene, Augustina; Kalyoncu, Mukaddes; Kavukcu, Salih; Kenan, Bahriye Uzun; Kucuk, Nuran; Kural, Bahar; Litwin, Mieczyslaw; Montini, Giovanni; Morello, William; Obrycki, Lukasz; Omer, Beyhan; Oner, Huseyin Adil; Ozdemir, Ebru Misirli; Ozkayin, Nese; Paripovic, Dusan; Pehlivanoglu, Cemile; Saygili, Seha; Schaefer, Franz; Schaefer, Susanne; Sonmez, Ferah; Tabel, Yilmaz; Tas, Nesrin; Tasdemir, Mehmet; Teixeira, Ana; Tekcan, Demet; Topaloglu, Rezan.
Affiliation
  • Aksu B; Department of Pediatrics Basic Sciences, Institute of Child Health, Istanbul University, Istanbul, Turkey. bagdagul@yahoo.com.
  • Afonso AC; Division of Pediatric Nephrology, Istanbul Faculty of Medicine, Istanbul University, Fatih, Istanbul, Turkey. bagdagul@yahoo.com.
  • Akil I; Division of Pediatric Nephrology, Centro Materno Infantil do Norte, Centro Hospitalar Universitário do Porto, Porto, Portugal.
  • Alpay H; Division of Pediatric Nephrology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey.
  • Atmis B; Division of Pediatric Nephrology, Faculty of Medicine, Marmara University, Istanbul, Turkey.
  • Aydog O; Pediatric Nephrology, Erzurum Training and Research Hospital, Erzurum, Turkey.
  • Bayazit AK; Division of Pediatric Nephrology, Faculty of Medicine, Cukurova University, Adana, Turkey.
  • Bayram MT; Division of Pediatric Nephrology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.
  • Bilge I; Division of Pediatric Nephrology, Faculty of Medicine, Cukurova University, Adana, Turkey.
  • Bulut IK; Division of Pediatric Nephrology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Buyukkaragoz B; Division of Pediatric Nephrology, Department of Pediatrics, School of Medicine, Koc University, Istanbul, Turkey.
  • Comak E; Division of Pediatric Nephrology, Faculty of Medicine, Ege University, Izmir, Turkey.
  • Demir BK; Division of Pediatric Nephrology, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Dincel N; Division of Pediatric Nephrology, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
  • Donmez O; Division of Pediatric Nephrology, Tepecik Training and Research Hospital, University of Health Sciences, Izmir, Turkey.
  • Durmus MA; Division of Pediatric Nephrology, Izmir Katip Celebi University Faculty of Medicine, Izmir, Turkey.
  • Dursun H; Division of Pediatric Nephrology, Dr. Behcet Uz Children Diseases Training and Research Hospital, University of Health Sciences, Izmir, Turkey.
  • Dusunsel R; Division of Pediatric Nephrology, Faculty of Medicine, Uludag University, Bursa, Turkey.
  • Duzova A; Department of Medical Microbiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Ertan P; Division of Pediatric Nephrology, Okmeydani Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Gedikbasi A; Division of Pediatric Nephrology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
  • Goknar N; Division of Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Guven S; Division of Pediatric Nephrology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey.
  • Hacihamdioglu D; Department of Rare Diseases, Institute of Child Health, Istanbul University, Istanbul, Turkey.
  • Jankauskiene A; Division of Pediatric Nephrology, Bagcilar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Kalyoncu M; Division of Pediatric Nephrology, Faculty of Medicine, Marmara University, Istanbul, Turkey.
  • Kavukcu S; Division of Pediatric Nephrology, Faculty of Medicine, Bahcesehir University, Istanbul, Turkey.
  • Kenan BU; Clinic of Pediatrics, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.
  • Kucuk N; Division of Pediatric Nephrology, Faculty of Medicine, Karadeniz Technic University, Trabzon, Turkey.
  • Kural B; Division of Pediatric Nephrology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Litwin M; Division of Pediatric Nephrology, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Montini G; Division of Pediatric Nephrology, Kartal Training and Research Hospital, Istanbul, Turkey.
  • Morello W; Department of Pediatrics, Health Science University Bakirkoy Sadi Konuk Training and Research Hospital, Istanbul, Turkey.
  • Obrycki L; Division of Nephrology, Kidney Transplantation and Hypertension, The Children's Memorial Health Institute, Warsaw, Poland.
  • Omer B; Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.
  • Oner HA; Department of Clinical Sciences and Community Health, University of Milano, Milan, Italy.
  • Ozdemir EM; Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.
  • Ozkayin N; Division of Nephrology, Kidney Transplantation and Hypertension, The Children's Memorial Health Institute, Warsaw, Poland.
  • Paripovic D; Department of Biochemistry, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Pehlivanoglu C; Division of Pediatric Nephrology, Istanbul Faculty of Medicine, Istanbul University, Fatih, Istanbul, Turkey.
  • Saygili S; Department of Pediatrics, Okmeydani Training and Research Hospital, Istanbul, Turkey.
  • Schaefer F; Division of Pediatric Nephrology, Faculty of Medicine, Trakya University, Edirne, Turkey.
  • Schaefer S; Division of Pediatric Nephrology, University Children's Hospital, Belgrade, Serbia.
  • Sonmez F; Division of Pediatric Nephrology, Umraniye Training and Research Hospital, Istanbul, Turkey.
  • Tabel Y; Division of Pediatric Nephrology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Tas N; Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, Heidelberg University, Heidelberg, Germany.
  • Tasdemir M; Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, Heidelberg University, Heidelberg, Germany.
  • Teixeira A; Division of Pediatric Nephrology, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey.
  • Tekcan D; Division of Pediatric Nephrology, Faculty of Medicine, Inonu University, Malatya, Turkey.
  • Topaloglu R; Division of Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Pediatr Nephrol ; 39(2): 483-491, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37462743
ABSTRACT

BACKGROUND:

One of the most common bacterial infections in childhood is urinary tract infection (UTI). Toll-like receptors (TLRs) contribute to immune response against UTI recognizing specific pathogenic agents. Our aim was to determine whether soluble TLR4 (sTLR4), soluble TLR5 (sTLR5) and interleukin 8 (IL-8) can be used as biomarkers to diagnose UTI. We also aimed to reveal the relationship between urine Heat Shock Protein 70 (uHSP70) and those biomarkers investigated in this study.

METHODS:

A total of 802 children from 37 centers participated in the study. The participants (n = 282) who did not meet the inclusion criteria were excluded from the study. The remaining 520 children, including 191 patients with UTI, 178 patients with non-UTI infections, 50 children with contaminated urine samples, 26 participants with asymptomatic bacteriuria and 75 healthy controls were included in the study. Urine and serum levels of sTLR4, sTLR5 and IL-8 were measured at presentation in all patients and after antibiotic treatment in patients with UTI.

RESULTS:

Urine sTLR4 was higher in the UTI group than in the other groups. UTI may be predicted using 1.28 ng/mL as cut-off for urine sTLR4 with 68% sensitivity and 65% specificity (AUC = 0.682). In the UTI group, urine sTLR4 levels were significantly higher in pyelonephritis than in cystitis (p < 0.0001). Post-treatment urine sTLR4 levels in the UTI group were significantly lower than pre-treatment values (p < 0.0001).

CONCLUSIONS:

Urine sTLR4 may be used as a useful biomarker in predicting UTI and subsequent pyelonephritis in children with UTI. A higher resolution version of the Graphical abstract is available as Supplementary information.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyelonephritis / Urinary Tract Infections Type of study: Prognostic_studies / Risk_factors_studies Limits: Child / Humans Language: En Journal: Pediatr Nephrol Journal subject: NEFROLOGIA / PEDIATRIA Year: 2024 Document type: Article Affiliation country: Turkey

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyelonephritis / Urinary Tract Infections Type of study: Prognostic_studies / Risk_factors_studies Limits: Child / Humans Language: En Journal: Pediatr Nephrol Journal subject: NEFROLOGIA / PEDIATRIA Year: 2024 Document type: Article Affiliation country: Turkey